Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica
- Substances:Secukinumab
Czechia- Participants:18–64 years · 65+ years
- Substances:Secukinumab
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Czechia81 clinical trials in Uherske Hradiste, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)
CzechiaStudy on the Effects of DFV890 for Pain Relief in Patients with Knee Osteoarthritis
CzechiaStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
CzechiaStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
CzechiaStudy on Tofacitinib for Patients with Early Active Axial Spondyloarthritis Who Did Not Respond to NSAIDs
CzechiaStudy on the Effects of AZD0780 on Cholesterol Levels in Adults Aged 18-75 with Dyslipidemia
CzechiaStudy on the Effects of Pentosan Polysulfate Sodium for Knee Osteoarthritis Pain in Adults
Czechia
CzechiaStudy on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Axial Spondyloarthritis
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on psoriatic arthritis treatments, including multiple trials evaluating novel therapies like zasocitinib and guselkumab for patients with varying treatment histories.
Additional investigations into innovative treatments for autoimmune conditions like Sjögren's Disease.
Comprehensive studies examining various treatments for knee osteoarthritis, including novel medications and comparative analyses of different therapeutic approaches.
Several trials exploring both topical and systemic treatments for improving mobility and reducing pain.
Important research into cardiovascular disease management, including trials for reducing major cardiovascular events and innovative treatments for hypertriglyceridemia.
Focus on novel therapeutic approaches for reducing cardiovascular risk factors and improving outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.